Drug application
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE (BUPIVACAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE)
Drugs@FDA NDA 022046 · HOSPIRA
Key facts
| Drug name | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE |
|---|---|
| Active ingredients | BUPIVACAINE HYDROCHLORIDE, EPINEPHRINE BITARTRATE |
| Application type | NDA |
| Application number | 022046 |
| Company | HOSPIRA |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | 0.5%;0.0091MG/ML |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission status date | Jul 13, 1983 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: